Title : Oral amphipathic peptides as therapeutic agents - Reddy_2006_Expert.Opin.Investig.Drugs_15_13 |
Author(s) : Reddy ST , Anantharamaiah GM , Navab M , Hama S , Hough G , Grijalva V , Garber DW , Datta G , Fogelman AM |
Ref : Expert Opin Investig Drugs , 15 :13 , 2006 |
Abstract : |
PubMedSearch : Reddy_2006_Expert.Opin.Investig.Drugs_15_13 |
PubMedID: 16370930 |
Title : D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice - Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1426 |
Author(s) : Navab M , Anantharamaiah GM , Hama S , Hough G , Reddy ST , Frank JS , Garber DW , Handattu S , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 25 :1426 , 2005 |
Abstract : |
PubMedSearch : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1426 |
PubMedID: 15845909 |
Title : Apolipoprotein A-I mimetic peptides - Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1325 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Hama S , Hough G , Grijalva VR , Yu N , Ansell BJ , Datta G , Garber DW , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 25 :1325 , 2005 |
Abstract : |
PubMedSearch : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1325 |
PubMedID: 15831812 |
Title : An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice - Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Wagner AC , Hama S , Hough G , Bachini E , Garber DW , Mishra VK , Palgunachari MN , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 25 :1932 , 2005 |
Abstract : |
PubMedSearch : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
PubMedID: 15961700 |
Title : Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis - Navab_2003_Curr.Opin.Investig.Drugs_4_1100 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Hough G , Wagner A , Nakamura K , Garber DW , Datta G , Segrest JP , Hama S , Fogelman AM |
Ref : Curr Opin Investig Drugs , 4 :1100 , 2003 |
Abstract : |
PubMedSearch : Navab_2003_Curr.Opin.Investig.Drugs_4_1100 |
PubMedID: 14582455 |